Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies

J Clin Oncol. 2021 Feb 10;39(5):397-418. doi: 10.1200/JCO.20.01719. Epub 2021 Jan 12.

Authors

Christoph Schmid¹, Jürgen Kuball², Gesine Bug³

Affiliations

¹ Department of Hematology and Oncology, Augsburg University Hospital, Augsburg, Germany.
² Department of Hematology and Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
³ Department of Medicine 2, Goethe University, Frankfurt am Main, Germany.

PMID: 33434060
DOI: 10.1200/JCO.20.01719

No abstract available

Publication types

Review

MeSH terms

Graft vs Leukemia Effect / immunology*
Hematologic Neoplasms / immunology
Hematologic Neoplasms / therapy*
Humans
Immunotherapy, Adoptive / methods*
Lymphocytes / immunology
Randomized Controlled Trials as Topic
Stem Cell Transplantation / methods*